Case Reports

. 2014 Dec;34(6):761-3.

doi: 10.1097/JCP.0000000000000217.

Sodium nitroprusside treatment of clozapine-refractory schizophrenia

João Paulo Maia-de-Oliveira¹, Paulo Belmonte-de-Abreu, Rodrigo A Bressan, Carolina Cachoeira, Glen B Baker, Serdar M Dursun, Jaime E C Hallak

Affiliations

Affiliation

¹ University of Sao Paulo and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil Federal University of Rio Grande do Norte Natal, Rio Grande do Norte, Brazil j.p@usp.br University of Rio Grande do Sul and National Institute of Science and Technology in Translational Medicine Porto Alegre, Rio Grande do Sul, Brazil Federal University of São Paulo and Schizophrenia Program and Interdisciplinary Laboratory of Clinical Neuroscience São Paulo, São Paulo, Brazil University of Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil Neurochemical Research Unit Department of Psychiatry University of Alberta and Center for Psychiatric Assessment and Therapeutics Alberta Health Services Alberta Hospital Edmonton Edmonton, Alberta, Canada and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil University of Sao Paulo and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil.

PMID: 25203464
DOI: 10.1097/JCP.0000000000000217

Case Reports

Sodium nitroprusside treatment of clozapine-refractory schizophrenia

João Paulo Maia-de-Oliveira et al. J Clin Psychopharmacol. 2014 Dec.

. 2014 Dec;34(6):761-3.

doi: 10.1097/JCP.0000000000000217.

Authors

João Paulo Maia-de-Oliveira¹, Paulo Belmonte-de-Abreu, Rodrigo A Bressan, Carolina Cachoeira, Glen B Baker, Serdar M Dursun, Jaime E C Hallak

Affiliation

¹ University of Sao Paulo and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil Federal University of Rio Grande do Norte Natal, Rio Grande do Norte, Brazil j.p@usp.br University of Rio Grande do Sul and National Institute of Science and Technology in Translational Medicine Porto Alegre, Rio Grande do Sul, Brazil Federal University of São Paulo and Schizophrenia Program and Interdisciplinary Laboratory of Clinical Neuroscience São Paulo, São Paulo, Brazil University of Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil Neurochemical Research Unit Department of Psychiatry University of Alberta and Center for Psychiatric Assessment and Therapeutics Alberta Health Services Alberta Hospital Edmonton Edmonton, Alberta, Canada and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil University of Sao Paulo and National Institute of Science and Technology in Translational Medicine Ribeirao Preto, São Paulo, Brazil.

PMID: 25203464
DOI: 10.1097/JCP.0000000000000217

No abstract available

PubMed Disclaimer

Cited by

Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
Kandratavicius L, Balista PA, Wolf DC, Abrao J, Evora PR, Rodrigues AJ, Chaves C, Maia-de-Oliveira JP, Leite JP, Dursun SM, Baker GB, Guimaraes FS, Hallak JE. Kandratavicius L, et al. BMC Neurosci. 2015 Mar 7;16:9. doi: 10.1186/s12868-015-0149-3. BMC Neurosci. 2015. PMID: 25887360 Free PMC article.
Multidimensional Connectomics and Treatment-Resistant Schizophrenia: Linking Phenotypic Circuits to Targeted Therapeutics.
MacKay MB, Paylor JW, Wong JTF, Winship IR, Baker GB, Dursun SM. MacKay MB, et al. Front Psychiatry. 2018 Oct 30;9:537. doi: 10.3389/fpsyt.2018.00537. eCollection 2018. Front Psychiatry. 2018. PMID: 30425662 Free PMC article. Review.
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.
Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Brown HE, et al. JAMA Psychiatry. 2019 Jul 1;76(7):691-699. doi: 10.1001/jamapsychiatry.2019.0151. JAMA Psychiatry. 2019. PMID: 30916714 Free PMC article. Clinical Trial.
The efficacy and safety of sodium nitroprusside in the treatment of schizophrenia: a meta-analysis.
Fei X, Li J, Wang S, Wang J, Guo C, Qisha R, Gao Y, Hu Y. Fei X, et al. Front Psychiatry. 2023 Nov 6;14:1271624. doi: 10.3389/fpsyt.2023.1271624. eCollection 2023. Front Psychiatry. 2023. PMID: 38025431 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Sodium nitroprusside treatment of clozapine-refractory schizophrenia

Affiliation

Sodium nitroprusside treatment of clozapine-refractory schizophrenia

Authors

Affiliation

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical